
0:27
A clinician discusses differences between injectable weekly semaglutide and the oral formulation, stating the oral form is ineffective for weight loss. He reviews clinical and literature experience with a "selective pulsing" dosing approach for the injectable and expresses skepticism about lifelong, high‑dose continuous therapy—citing cost and questionable logic of using the highest tolerated dose indefinitely.










